The phrase "availability of compatible" is correct and usable in written English.
It can be used when discussing the presence or accessibility of items or systems that can work together or are suitable for a particular purpose.
Example: "The availability of compatible software is crucial for ensuring seamless integration with our existing systems."
Alternatives: "accessibility of compatible" or "presence of compatible".
The major challenges in biobutanol production are low butanol titer, availability of compatible feedstocks, and product inhibition.
As such, current and emerging sequencing strategies benefit from the availability of compatible physical maps guiding clone selection, or facilitating assemblies that may also enhance validation efforts [ 1, 3, 4].
In our study low-density patches produced significantly fewer flowers than high-density ones which may limit the availability of compatible pollen, but fruit set did not decrease in low-density patches (Fig. 2).
However, this approach is far from being versatile since it relies on the availability of compatible functional groups on both PEG and the host surface as well as on their respective surface densities.
Stigmas (84.2 %) had pollen on them after all stamens had dehisced, which was significantly higher than the final fruit set (t = 15.85, df = 476, P < 0.001), indicating that L. borealis received numerous pollinator visits during anthesis but that fruit production was significantly limited by the availability of compatible pollen.
Medical researchers frequently attribute this to the availability of medically compatible living kidney donors, who are usually kin.
The two PM2.5 mass and composition data sets employed in the source apportionments were selected based on their ready availability for analysis, the similar availability of a compatible daily mortality record for health effects analysis, and the fact that their PM2.5 composition analyses were similar in many ways to those characteristics available to researchers from the new U.S. EPA PM2.5 STN.
The availability of MRI-compatible cardiac implantable electronic devices varies by country, but this is driven primarily by country-specific regulatory approvals.
The possibility of precise nanoparticles size control, as long as the availability of bio-compatible covering, makes them suitable for biomedical applications.
To answer these questions, extensive research has been conducted that has led to an expansion of the availability of water-compatible Lewis acids and catalysts.
The accuracy of perfusion and permeability measurements is dependent on the compactness of the bolus injection of the contrast medium and in this regard, the recent availability of MR-compatible automated injection devices is welcome.
